Globus Medical GMED Musculoskeletal Solutions — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's musculoskeletal solutions — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's musculoskeletal solutions — net sales?
- Globus Medical (GMED) reported musculoskeletal solutions — net sales of $732.98M in Q1 2026.
- How has Globus Medical's musculoskeletal solutions — net sales changed year-over-year?
- Globus Medical's musculoskeletal solutions — net sales increased by 27.3% year-over-year, from $575.93M to $732.98M.
- What does musculoskeletal solutions — net sales mean?
- The total revenue earned from selling spinal and orthopedic surgical hardware and instruments.
- How do you interpret musculoskeletal solutions — net sales?
- An increase suggests strong demand for the company's core orthopedic product line and successful sales execution, while a decrease may indicate market share loss or pricing pressure in the spinal implant sector.
- How does musculoskeletal solutions — net sales compare across companies?
- This is comparable to the core orthopedic or spinal implant revenue segments reported by major medical device competitors, often serving as a primary indicator of market share in the musculoskeletal space.